Fairfax Financial · Q3 2025 · Published 6 November 2025 · Interim report
Fairfax Financial earned $1,151.7 million ($55.90 a share) in Q3 2025 on a 92.0% combined ratio and agreed to sell Eurolife's life business to Eurobank for about $940 million; book value per share reached $1,203.65.
Fairfax Financial's interim report for the nine months to September 30, 2025 holds the unaudited financial statements and the management's discussion and analysis. Third-quarter net earnings attributable to shareholders rose to $1,151.7 million from $1,030.8 million, and nine-month earnings reached $3,534.1 million. Underwriting profit was $540.3 million in the quarter, a 92.0% combined ratio, with catastrophe losses of $132.1 million at the Global Insurers and Reinsurers. Book value per basic share rose 13.6% in nine months to $1,203.65, and Fairfax bought back 541,794 shares for $856.8 million. After the quarter Fairfax agreed to sell its 80% stake in Eurolife's life insurance business to Eurobank and completed the purchase of The Keg Royalties Income Fund.
Consolidated share of profit of associates of $305.0 in the third quarter of 2025 principally reflected share of profit of $140.7 from Eurobank, $67.9 from Poseidon and $38.8 from EXCO.Show in the letter ›
Concurrently, the company will purchase a 45.0% equity interest in Eurobank’s Cyprus non-life insurance company ERB Asfalistiki (“ERBA”) for cash consideration of approximately $68 (€59.0), with an option to acquire the remainder of ERBA in the future.Show in the letter ›
During the first nine months of 2025 the company sold 96.9 million shares or an approximate 2.7% equity interest in Eurobank for gross proceeds of $248.5 (€232.9) which decreased the company's equity interest to 31.7% and resulted in the recognition of a realized gain of $58.5 in the consolidated statement of earnings.Show in the letter ›
The sales were mandatory technical adjustments to the company’s significant equity interest in Eurobank.Show in the letter ›